Star Health and Allied Insurance Company profit and loss

Latest FY26

EBITDA: ₹747cr−12.6% on FY25
Net profit: ₹557cr−13.8% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025

Expenses
	17.3	6.9	6.3
	1,401	747	855
	1,401	747	855
Profit
	1,418	754	861
	1,054	557	646
Per share
	₹17.91	₹9.47	₹11.01
Revenue detail — as filed
	—	17,371	15,594
	—	767	766
Expense detail — as filed
	—	1,983	1,693
	—	2,673	2,241
	—	2,673	2,241
	—	71.8	51.2
	—	0.3	0.5
Profit build-up — alternate / pre-Ind-AS tags
	—	754	861
	—	754	861
	—	197	215
	—	557	646
	—	557	646
Per share — as-filed variants
	—	₹9.47	₹11.01
	—	₹9.47	₹11.01
Appropriations & transfers
	—	363	393
Insurance — revenue account (Policyholders')
	—	16,597	14,822
	—	18,622	16,781
	—	17,650	15,525
	—	2,960	2,541
	—	71.4	50.8
	—	11,287	9,854
	12,536	11,375	10,419
	—	88.3	566
	—	11,978	10,688
	—	21,811	20,223
Insurance — Shareholders' account
	—	826	912
	—	461	514
	—	363	393
	—	0.0	0.0
	—	0.0	0.0
Insurance — result & transfers
	—	−412	−379
	—	363	393
	—	2.5	5.5
Insurance — IRDAI ratios (as filed, not percentages)
	2.05×	2.05×	2.21×
	₹2.05	₹2.05	₹2.21
	—	₹1.00	₹1.01
	—	₹0.69	₹0.70
	—	₹0.95	₹0.93
	—	₹0.32	₹0.31
Direct-method operating receipts — filed in the P&L block
	—	4,550	5,249
Regulatory disclosures — filed alongside, not part of the P&L
	—	−₹1.00	₹0.00
	—	₹1.00	₹1.00
	—	₹2.00	₹1.00

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

STARHEALTH₹519.25

Star Health and Allied Insurance Company Ltd.

· Banking & Finance

Annual Quarterly₹ CrorePeersNIVABUPA ICICIGI UCOBANK PINELABS AADHARHFC AAVAS NUVAMA ABSLAMCMcap ₹30,539 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Other Income	6.3	6.9	17.3
Expenses
EBITDA	854.8	747.4	1,400.7
EBIT	854.8	747.4	1,400.7
Profit
Pretax Income	861.1	754.3	1,418.0
Net Income	645.9	557.0	1,054.1
Per Share
Basic EPS	11.01	9.47	17.91
Revenue Detail — as filed
+ Operating Income	15,594.0	17,370.9	—
+ Income from Investments (net)	765.5	767.3	—
Expense Detail — as filed
+ Employee Remuneration & Welfare	1,692.9	1,983.2	—
+ Commission (net)	2,240.7	2,673.3	—
+ Commission & Brokerage (net)	2,240.7	2,673.3	—
+ Non-operating Expense	51.2	71.8	—
+ Non-operating Provision — Doubtful Debts	0.5	0.3	—
Profit Build-up — Alternate / Pre-Ind-AS Tags
Profit before Extraordinary Items	861.1	754.3	—
Profit / (Loss) before Tax — alt tag	861.1	754.3	—
+ Provision for Tax	215.2	197.3	—
Profit / (Loss) after Tax	645.9	557.0	—
Profit Carried to Balance Sheet	645.9	557.0	—
Per Share — as-filed variants
Basic & Diluted EPS before Extraordinary (not annualised)	11.01	9.47	—
Basic & Diluted EPS after Extraordinary (not annualised)	11.01	9.47	—
Appropriations & Transfers
+ Transfer to Profit & Loss Account	393.3	362.6	—
Insurance — Revenue Account (Policyholders')
Premium Earned	14,822.2	16,596.7	—
+ Gross Premiums Written	16,781.4	18,621.9	—
+ Net Premium Written	15,525.2	17,650.3	—
+ Operating Expenses — Insurance Business	2,540.6	2,959.8	—
+ Non-operating Expenses — Non-insurance	50.8	71.4	—
+ Claims Paid	9,853.7	11,286.9	—
+ Incurred Claims	10,419.4	11,375.2	12,535.7
+ Change in Outstanding Claims	565.7	88.3	—
+ Payments — Premiums, Claims, Annuities & Benefits	10,687.9	11,978.3	—
+ Receipts — Premiums, Claims, Annuities & Benefits	20,223.2	21,811.4	—
Insurance — Shareholders' Account
+ Income — Shareholders' Account	912.3	826.1	—
+ Shareholders' Investment Income	513.5	461.0	—
+ Transfer from Policyholders' Fund	393.3	362.6	—
With Unrealised Gains	0.0	0.0	—
Without Unrealised Gains	0.0	0.0	—
Insurance — Result & Transfers
Underwriting Profit / (Loss)	-378.5	-411.6	—
Operating Profit / (Loss)	393.3	362.6	—
+ Other Income — Shareholders' Account	5.5	2.5	—
Insurance — IRDAI Ratios (as filed, not percentages)
Solvency Ratio (x, one scale)	2.21	2.05	2.05
Solvency Ratio (as filed)	2.21	2.05	2.05
Combined Ratio	1.01	1.00	—
Incurred Claim Ratio	0.70	0.69	—
Net Retention Ratio	0.93	0.95	—
Expenses of Management Ratio	0.31	0.32	—
Direct-method Operating Receipts — filed in the P&L block
+ Other Operating Cash Payments	5,249.3	4,550.4	—
Regulatory Disclosures — filed alongside, not part of the P&L
Investor Complaints — During the Period	0.00	-1.00	—
Investor Complaints — Received	1.00	1.00	—
Investor Complaints — Disposed	1.00	2.00	—
Other Filed Concepts — mapped but not yet placed in the schedule
Operating Expenses	15,200.7	17,008.3	—
Other Operating Expenses	847.8	976.7	—

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.